{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001403130","attributes":{"CHIP_ANTIBODY":["H3K27ac"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["184"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S015TI/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"1.4M","NAME":"S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S015TI/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"dd3cb33d363abffeba7b351a0423c909"},{"FORMAT":"BED","SIZE":"1.7M","NAME":"S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S015TI/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1d57b34066da1aaeb2c936a00e9979a1"},{"FORMAT":"bigWig","SIZE":"713M","NAME":"S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S015TI/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"18c765e8a4d57d12f87ae5752dd11add"},{"FORMAT":"Text","SIZE":"2.0M","NAME":"S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S015TI/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S015TIH1.ERX1489874.H3K27ac.bwa.GRCh38.20160527.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"65114eeb6b536b9f9bffdedadf09a923"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"bone marrow","SAMPLE_NAME":"S015TI","sample_barcode":"S015TIH1","attributes":{"MARKERS":["MLL-AF9 positive, 96% blasts, normal BRE"],"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["25 - 30"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"TREATMENT":["NA"],"BIOMATERIAL_PROVIDER":["Radboudumc, Nijmegen, Netherlands"],"CELL_TYPE":["blast cell"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["bone marrow"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SAMPLE_ONTOLOGY_URI":[{"url":"1","label":"UBERON_0002371"}],"GENDER":["male"],"DONOR_ID":["S015TI"],"DONOR_SEX":["Male"]},"SAMPLE_ID":"EGAN00001381991","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}